{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Ficis-for-hcc-overview-hD6m2d_R","width":444,"version":"1.0","type":"rich","title":"An Expert Overview of Immunotherapy for Advanced HCC","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/b60103e6-b377-4b57-a602-453b56f6e4e6/hcc-dm-wc-tu-podcast-icis.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/12cf1edf-6d0f-4c24-803c-a329de027f5f\" height=\"200\" width=\"100%\" title=\"An Expert Overview of Immunotherapy for Advanced HCC\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, as they provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma."}